Europe HLA Typing for Transplant Market Report 2019

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 HLA Typing for Transplant Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Molecular Assays Market Performance (Volume)
  • 2.1.2 Non-Molecular Assays Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.2.1 Molecular Assays Market Performance (Value)
  • 2.2.2 Non-Molecular Assays Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Diagnostic Applications Market Performance (Volume)
  • 3.1.2 Research Applications Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Thermo Fisher Scientific
  • 4.1.1 Thermo Fisher Scientific Profiles
  • 4.1.2 Thermo Fisher Scientific Product Information
  • 4.1.3 Thermo Fisher Scientific HLA Typing for Transplant Business Performance
  • 4.1.4 Thermo Fisher Scientific HLA Typing for Transplant Business Development and Market Status
• 4.2 Immucor
  • 4.2.1 Immucor Profiles
  • 4.2.2 Immucor Product Information
  • 4.2.3 Immucor HLA Typing for Transplant Business Performance
  • 4.2.4 Immucor HLA Typing for Transplant Business Development and Market Status
• 4.3 Olerup SSP
  • 4.3.1 Olerup SSP Profiles
  • 4.3.2 Olerup SSP Product Information
  • 4.3.3 Olerup SSP HLA Typing for Transplant Business Performance
  • 4.3.4 Olerup SSP HLA Typing for Transplant Business Development and Market Status
• 4.4 Qiagen
  • 4.4.1 Qiagen Profiles
  • 4.4.2 Qiagen Product Information
  • 4.4.3 Qiagen HLA Typing for Transplant Business Performance
  • 4.4.4 Qiagen HLA Typing for Transplant Business Development and Market Status
• 4.5 Bio-Rad Laboratories
  • 4.5.1 Bio-Rad Laboratories Profiles
  • 4.5.2 Bio-Rad Laboratories Product Information
  • 4.5.3 Bio-Rad Laboratories HLA Typing for Transplant Business Performance
  • 4.5.4 Bio-Rad Laboratories HLA Typing for Transplant Business Development and Market Status
• 4.6 Illumina
  • 4.6.1 Illumina Profiles
  • 4.6.2 Illumina Product Information
  • 4.6.3 Illumina HLA Typing for Transplant Business Performance
  • 4.6.4 Illumina HLA Typing for Transplant Business Development and Market Status
• 4.7 Affymetrix
  • 4.7.1 Affymetrix Profiles
  • 4.7.2 Affymetrix Product Information
  • 4.7.3 Affymetrix HLA Typing for Transplant Business Performance
  • 4.7.4 Affymetrix HLA Typing for Transplant Business Development and Market Status
• 4.8 F. Hoffmann-LA-Roche
  • 4.8.1 F. Hoffmann-LA-Roche Profiles
  • 4.8.2 F. Hoffmann-LA-Roche Product Information
  • 4.8.3 F. Hoffmann-LA-Roche HLA Typing for Transplant Business Performance
  • 4.8.4 F. Hoffmann-LA-Roche HLA Typing for Transplant Business Development and Market Status
• 4.9 Luminex
  • 4.9.1 Luminex Profiles
  • 4.9.2 Luminex Product Information
  • 4.9.3 Luminex HLA Typing for Transplant Business Performance
  • 4.9.4 Luminex HLA Typing for Transplant Business Development and Market Status
• 4.10 Abbott Laboratories
  • 4.10.1 Abbott Laboratories Profiles
  • 4.10.2 Abbott Laboratories Product Information
  • 4.10.3 Abbott Laboratories HLA Typing for Transplant Business Performance
  • 4.10.4 Abbott Laboratories HLA Typing for Transplant Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Europe HLA Typing for Transplant Sales (K Units) and Market Share by Manufacturers 2014-2020
• 5.2 Europe HLA Typing for Transplant Revenue (M USD) and Market Share by Manufacturers 2014-2020
• 5.3 Europe HLA Typing for Transplant Price (USD/Unit) of Manufacturers 2014-2020
• 5.4 Europe HLA Typing for Transplant Gross Margin of Manufacturers 2014-2020
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany HLA Typing for Transplant Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.1.2 Germany HLA Typing for Transplant Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.1.3 Germany HLA Typing for Transplant Price (USD/Unit) of Manufacturers 2014-2020
  • 6.1.4 Germany HLA Typing for Transplant Gross Margin of Manufacturers 2014-2020
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK HLA Typing for Transplant Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.2.2 UK HLA Typing for Transplant Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.2.3 UK HLA Typing for Transplant Price (USD/Unit) of Manufacturers 2014-2020
  • 6.2.4 UK HLA Typing for Transplant Gross Margin of Manufacturers 2014-2020
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France HLA Typing for Transplant Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.3.2 France HLA Typing for Transplant Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.3.3 France HLA Typing for Transplant Price (USD/Unit) of Manufacturers 2014-2020
  • 6.3.4 France HLA Typing for Transplant Gross Margin of Manufacturers 2014-2020
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia HLA Typing for Transplant Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.4.2 Russia HLA Typing for Transplant Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.4.3 Russia HLA Typing for Transplant Price (USD/Unit) of Manufacturers 2014-2020
  • 6.4.4 Russia HLA Typing for Transplant Gross Margin of Manufacturers 2014-2020
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux HLA Typing for Transplant Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.5.2 Benelux HLA Typing for Transplant Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.5.3 Benelux HLA Typing for Transplant Price (USD/Unit) of Manufacturers 2014-2020
  • 6.5.4 Benelux HLA Typing for Transplant Gross Margin of Manufacturers 2014-2020
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy HLA Typing for Transplant Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.6.2 Italy HLA Typing for Transplant Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.6.3 Italy HLA Typing for Transplant Price (USD/Unit) of Manufacturers 2014-2020
  • 6.6.4 Italy HLA Typing for Transplant Gross Margin of Manufacturers 2014-2020
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain HLA Typing for Transplant Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.7.2 Spain HLA Typing for Transplant Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.7.3 Spain HLA Typing for Transplant Price (USD/Unit) of Manufacturers 2014-2020
  • 6.7.4 Spain HLA Typing for Transplant Gross Margin of Manufacturers 2014-2020
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 HLA Typing for Transplant Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.8.2 HLA Typing for Transplant Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.8.3 HLA Typing for Transplant Price (USD/Unit) of Manufacturers 2014-2020
  • 6.8.4 HLA Typing for Transplant Gross Margin of Manufacturers 2014-2020
  • 6.8.5 Market Concentration

7 Europe HLA Typing for Transplant Market Performance (Sales Point)

• 7.1 Europe HLA Typing for Transplant Sales (K Units) and Market Share by Regions 2014-2020
• 7.2 Europe HLA Typing for Transplant Revenue (M USD) and Market Share by Regions 2014-2020
• 7.3 Europe HLA Typing for Transplant Price (USD/Unit) by Regions 2014-2020
• 7.4 Europe HLA Typing for Transplant Gross Margin by Regions 2014-2020

8 Development Trend for Regions (Sales Point)

• 8.1 Europe HLA Typing for Transplant Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.2 Germany HLA Typing for Transplant Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.3 UK HLA Typing for Transplant Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.4 France HLA Typing for Transplant Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.5 Russia HLA Typing for Transplant Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.6 Benelux HLA Typing for Transplant Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.7 Italy HLA Typing for Transplant Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.8 Spain HLA Typing for Transplant Sales and Growth, Sales Value and Growth Rate2014-2020

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Diagnostic Applications Industry
• 11.2 Research Applications Industry

12 Market Forecast 2021-2026

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
  • 12.1.1 Europe HLA Typing for Transplant Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
  • 12.1.2 Europe HLA Typing for Transplant Sales (K Units) and Growth Rate 2021-2026
  • 12.1.3 Germany HLA Typing for Transplant Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.4 UK HLA Typing for Transplant Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.5 France HLA Typing for Transplant Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.6 Russia HLA Typing for Transplant Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.7 Benelux HLA Typing for Transplant Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.8 Italy HLA Typing for Transplant Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.9 Spain HLA Typing for Transplant Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
  • 12.2.1 Overall Market Performance
  • 12.2.2 Molecular Assays Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.2.3 Non-Molecular Assays Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.3 Sales Forecast by Application 2021-2026
  • 12.3.1 Overall Market Performance
  • 12.3.2 Diagnostic Applications Sales and and Growth Rate 2021-2026
  • 12.3.3 Research Applications Sales and and Growth Rate 2021-2026
• 12.4 Price (USD/Unit) and Gross Profit Forecast
  • 12.4.1 Europe HLA Typing for Transplant Price (USD/Unit) Trend 2021-2026
  • 12.4.2 Europe HLA Typing for Transplant Gross Profit Trend 2021-2026

13 Conclusion